Title |
Known data on CoVid-19 infection linked to type-2 diabetes
|
Authors |
U. Vidhya Rekha1, M. Anita2, S. Bhuminathan1 & K. Sadhana1
|
Affiliation |
1Department of Public Health Dentistry, Sree Balaji Dental College and Hospital, Pallikaranai, Chennai-600100, India; 2Department of Prosthodontics, Sree Balaji Dental College and Hospital, Pallikaranai, Chennai 600100, India
|
|
*Corresponding author; Dr. U. Vidhya Rekha – E-mail: drvidhyarekha@gmail.com
|
Article Type |
Review Article
|
Date |
Received August 2, 2021; Revised August 30, 2021; Accepted August 30, 2021, Published August 31, 2021
|
Abstract |
It is of interest to document the
known data on CoVid-19 infection linked to type-2 diabetes.
Hyperglycemia, inhibition of neutrophil chemotaxis, altered cytokine
synthesis, phagocytic cell dysfunction, impaired T cell-mediated
immune responses, and inadequate microbia were all seen in people
with Diabetes. Individuals with diabetes have also been shown to
elevate levels of the proinflammatory cytokine, especially IL-1,
IL-6, and tumor necrosis factor-alpha (TNF-alpha), and different
markers such as C reactive protein, D-dimer, and fibrinogen. This
will prolong the cytokine storms and lead to severe illness in
diabetic individuals with COVID- 19 infection. The role of acute
glycemic control after COVID- 19 manifestation on clinical outcomes
has not been known in detail.
|
Keywords |
CoVid-19; type-2 diabetes; Inflammatory cytokines.
|
Citation |
Vidhya Rekha et al. Bioinformation 17(8): 772-775 (2021)
|
Edited by |
P Kangueane
|
ISSN |
0973-2063
|
Publisher |
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|